IL18 and type 2 diabetes mellitus: Regular coffee intake can lower the levels of proinflammatory biomarkers (such as L-1β, IL-6, TNF-α, C-reactive protein, monocyte chemotactic protein 1, vascular cell adhesion molecule 1, C-peptides, endothelial-leukocyte adhesion molecule 1 and interleukin 18 [IL-18]) in healthy, obese and T2D-affected individuals.